Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

J Kota, RR Chivukula, KA O'Donnell, EA Wentzel… - Cell, 2009 - cell.com
Therapeutic strategies based on modulation of microRNA (miRNA) activity hold great
promise due to the ability of these small RNAs to potently influence cellular behavior. In this …

[HTML][HTML] Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy

CD Markert, A Atala, JK Cann, G Christ, M Furth… - PM&R, 2009 - Elsevier
Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and
cardiac muscle are termed mesenchymal stem cells. These cells were first identified in the …

Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice

PT Martin, R Xu, LR Rodino-Klapac… - … of Physiology-Cell …, 2009 - journals.physiology.org
The cytotoxic T cell (CT) GalNAc transferase, or Galgt2, is a UDP-GalNAc: β1, 4-N-
acetylgalactosaminyltransferase that is localized to the neuromuscular synapse in adult …

Therapy for neuromuscular disorders

ALH Arnett, JR Chamberlain… - Current opinion in genetics …, 2009 - Elsevier
Research into therapeutic approaches for both recessive and dominant neuromuscular
disorders has made great progress over the past few years. In the field of gene therapy …

[HTML][HTML] Therapeutic delivery of miR-26a inhibits cancer cell proliferation and induces tumor-specific apoptosis

J Kota, RR Chivukula, KA O'Donnell, EA Wentzel… - Cell, 2009 - ncbi.nlm.nih.gov
Therapeutic strategies based on modulation of microRNA (miRNA) activity hold great
promise due to the ability of these small RNAs to potently influence cellular behavior. In this …

Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector–mediated gene therapy

VM Velazquez, DG Bowen… - Blood, The Journal of the …, 2009 - ashpublications.org
Recombinant adeno-associated virus (rAAV) vectors are considered promising for human
gene replacement because they facilitate stable expression of therapeutic proteins in …

Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders

BM Koppanati, J Li, X Xiao, PR Clemens - Gene therapy, 2009 - nature.com
One of the major challenges in the treatment of primary muscle disorders, which often affect
many muscle groups, is achieving efficient, widespread transgene expression in muscle. In …

The" Excellence in Translational Medicine" and" Bedside-to-Bench" Awards 2007–08

RJ Ablin, FM Marincola, PG Natali - Journal of Translational Medicine, 2009 - Springer
In a continuing endeavor to recognize outstanding contributions in the field of translational
medicine, the Editorial Board of the Journal of Translational Medicine (JTM) established" …

Fibrotic pathways in the dystrophin deficient heart

A Wakefield - 2009 - research.usq.edu.au
Duchenne muscular dystrophy is the most prevalent and severe of the muscular dystrophies.
A hallmark of dystrophic muscle is fibrosis which is a result of chronic cycles of degeneration …

Ongoing cellular responses to transgene products encoded by recombinant adeno-associated virus (rAAV) vectors

VM Best - 2009 - rave.ohiolink.edu
Recombinant adeno-associated virus (rAAV) vectors are considered promising for human
gene replacement because they facilitate the stable expression of numerous therapeutic …